Michael Byrnes
2023 - eFFECTOR Therapeutics
In 2023, Michael Byrnes earned a total compensation of $826.6K as Chief Financial Officer at eFFECTOR Therapeutics, a 58% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $171,000 |
|---|---|
| Option Awards | $171,776 |
| Salary | $450,000 |
| Other | $33,817 |
| Total | $826,593 |
Byrnes received $450K in salary, accounting for 54% of the total pay in 2023.
Byrnes also received $171K in non-equity incentive plan, $171.8K in option awards and $33.8K in other compensation.
Rankings
In 2023, Michael Byrnes' compensation ranked 1,338th out of 2,647 executives tracked by ExecPay. In other words, Byrnes earned more than 49.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,338 out of 2,647 | 50th |
Division Manufacturing | 801 out of 1,447 | 45th |
Major group Chemicals And Allied Products | 523 out of 817 | 36th |
Industry group Drugs | 510 out of 783 | 35th |
Industry Pharmaceutical Preparations | 351 out of 555 | 37th |
Source: SEC filing on April 26, 2024.
Byrnes' colleagues
We found two more compensation records of executives who worked with Michael Byrnes at eFFECTOR Therapeutics in 2023.